R Retreatment in 1st Relapsed DLBCL
- Status
- UNKNOWN
- Phase
- PHASE2
Clinical Trials Related to Rituximab
Related studies linked through entity extraction aliases.
Combination Chemotherapy and Rituximab in Treating Patients With Diffuse Large B-Cell Non-Hodgkin Lymphoma
- Status
- UNKNOWN
- Phase
- PHASE2
Study of Bendamustine/Rituxan Induction Chemotherapy With Revlimid Maintenance for Relapsed/Refractory CLL and SLL
- Status
- COMPLETED
- Phase
- PHASE2
Vorinostat, Rituximab, and Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage II, Stage III, or Stage IV Diffuse Large B-Cell Lymphoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Infusion of Expanded Cord Blood T Cells
- Status
- WITHDRAWN
- Phase
- PHASE1
Gemcitabine Hydrochloride, Cyclophosphamide, Vincristine Sulfate, Prednisolone, and Rituximab in Treating Patients With Newly Diagnosed Diffuse Large B-Cell Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
High-dose Chemotherapy With Rituximab for Adults With Aggressive Large B-cell Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Treatment of TNFa Naive Patients With Poor Prognosis Rheumatoid Arthritis
- Status
- COMPLETED
- Phase
- NA
Study of Bortezomib in Combination With Cyclophosphamide and Rituximab
- Status
- COMPLETED
- Phase
- PHASE2
Optimized Donor Selection, Nonmyeloablative BMT for B-cell Lymphomas With Post-transplantation Cy and Rituximab
- Status
- TERMINATED
- Phase
- PHASE2
Rituximab Plus Sargramostim (GM-CSF) In Patients With Chronic Lymphocytic Leukemia
- Status
- COMPLETED
- Phase
- PHASE2
S0902 Bendamustine and Rituximab in Treating Patients With B-Cell Chronic Lymphocytic Leukemia That Has Not Responded to Previous Treatment
- Status
- WITHDRAWN
- Phase
- PHASE2
The Use of Rituximab in Acute Thrombotic Thrombocytopenic Purpura (TTP)
- Status
- COMPLETED
- Phase
- PHASE2
A Protocol Based Treatment for Debilitating Fibrosing Skin Disorders With (Anti-CD 20), Rituximab, Evaluating Safety and Efficacy
- Status
- COMPLETED
- Phase
- PHASE2
Study to Assess the Effectiveness of RCHOP With or Without VELCADE in Previously Untreated Non-Germinal Center B-Cell-like Diffuse Large B-Cell Lymphoma Patients
- Status
- COMPLETED
- Phase
- PHASE2
A Pharmacokinetic Study of Subcutaneous and Intravenous Rituximab in Participants With Follicular Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1
Cladribine With Simultaneous or Delayed Rituximab to Treat Hairy Cell Leukemia
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Mantel Cell Lymphoma Efficacy of Rituximab Maintenance
- Status
- COMPLETED
- Phase
- PHASE3
Vorinostat, Fludarabine Phosphate, Cyclophosphamide, and Rituximab in Treating Patients With Previously Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Diffuse Large B Cell Non-Hodgkin's Lymphoma in the Vulnerable/Frail Elderly. A Multicentric Randomized Phase II Trial
- Status
- COMPLETED
- Phase
- PHASE2